Conclusions: Virtual visits have increased exponentially during the COVID-19 pandemic. Current evidence support the use of virtual visits to replace post discharge in-person visits. A structured approach is recommended by current guidelines. Tele-monitoring interventions can range from low to high complexity and should match the risk profile of the patient. Regardless of the tele-monitoring platform, the integration with clinical support for medical therapy optimization cannot be overemphasized. Racial and social disparities in telemedicine implementation have been reported and further research is needed.
DOI: https://doi.org/10.31083/j.rcm2202046
Annotations: telemonitoring; heart failure with reduced ejection fraction; telemedicine, COVID-19
